Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
about
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyCombining radiotherapy and cancer immunotherapy: a paradigm shiftInfluence of Sugar Amine Regiochemistry on Digitoxigenin Neoglycoside Anticancer ActivityEarly downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450Trial watch: Cardiac glycosides and cancer therapyBleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cellsMolecular mechanisms of ATP secretion during immunogenic cell deathScreening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity SetSynthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress.Intracellular calcium regulates nonsense-mediated mRNA decay.Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity.Classification of current anticancer immunotherapiesCancer as a channelopathy: ion channels and pumps in tumor development and progressionCombinatorial strategies for the induction of immunogenic cell death.Induction of immunogenic cell death by chemotherapeutic platinum complexes.Digoxin use and the risk for colorectal cancerExtracellular Antibody Drug Conjugates Exploiting the Proximity of Two ProteinsMolecular and Translational Classifications of DAMPs in Immunogenic Cell Death.Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effectsSulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.Noncanonical roles of the immune system in eliciting oncogene addictionDevelopment of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma.Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.Danger signalling during cancer cell death: origins, plasticity and regulation.Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients.Mitochondrial regulation of cell death: a phylogenetically conserved controlImmune-related gene signatures predict the outcome of neoadjuvant chemotherapy.Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials.Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategiesThe interplay between the immune system and chemotherapy: emerging methods for optimizing therapy.ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.
P2860
Q26765115-2E98F6D0-023F-4B82-8CDD-EA8BF98047C4Q26781215-1AA91647-5578-43D9-A274-060A18081AA1Q27004011-9205DCFE-2DE5-4132-8F5F-DB750A7786F1Q27021428-C21624A2-C815-40B1-967D-CDBD776368E3Q28390870-4A74CE18-91A6-4744-876C-A7C959756D93Q28395627-D005E410-FD12-42A9-B70A-A50CA4A95251Q28395830-D07BF752-382B-4803-9265-B1B015441994Q28533749-67E028A4-85F8-4C67-BE0C-F9B89AE6C4ECQ30408773-87A8D842-A07E-4C54-9ECC-54DEDDED9DE5Q33776379-0B70B8F7-DEE1-4C6C-A74A-78EA45479976Q33776397-6C2D6A90-B6E0-4683-9638-1F0E10B7D54EQ34021019-80891D04-3186-48D5-A581-23B543BAD9E7Q34628990-CBD1127D-A785-4A74-9E80-2D6FB75C23F2Q35025948-79A5338C-8BF7-4402-8856-1F414E261A34Q35149637-581C6AAE-5B57-497C-950D-F7451F45E293Q35184108-6CFAEF07-89A6-432C-952F-9306995E4A12Q35535140-2A60B17D-BD0B-4CD8-BE7A-543604495C4EQ35601291-FE7E23EF-EE8D-4AD8-B0BC-32E60315AB48Q35917969-BB68508A-BFFF-4E9A-BDB2-246AC31E39C9Q36081864-79D05D8D-6362-4035-A7B8-F597BA70F336Q36301061-2E618F0B-9327-4034-AA9D-A8A78655BDB3Q36476123-0D90C4C0-CCA9-47D0-A697-441BC48E5702Q36499777-B708CBFD-FC25-44F1-95D1-838F34C94E40Q36931816-E9AC74A7-FF9E-4ECA-9869-450E163CF063Q37173140-8DCFFF76-2E49-4B59-818A-1610EAAF1EE8Q37201739-419A18D9-816C-4652-9640-9E7EFEC5F3CDQ37335249-E38BBF78-240C-4392-91C5-23856D2A4610Q37379408-A939ADC5-9444-485C-8E4D-34AEAC5A2321Q37381745-FF2D4758-88FC-4691-A196-D2185E94AA87Q37536659-CE63183B-5A6B-4571-BD46-5A2B85435635Q37665204-4A537998-8A63-41EE-B7A5-C99D1784B0F7Q37689374-F279A1F8-40CA-47BE-9689-CD3024F263F3Q37698153-C82451E0-92C1-43CD-A1B5-8998B7144CAFQ37732220-C0C5AA0C-8E94-4E05-82D6-99F3205D3FEFQ38113122-6581BA1F-0E9F-40F9-95B2-239803F9BE1CQ38119845-A8C39468-8BD9-4C1B-9007-4AA0971E858CQ38139255-649349B7-75C9-4FD6-995D-FCBB8E977C54Q38168953-C509FAFA-F55B-49B8-BF25-03699EEB5952Q38184935-CDF75B9B-4F70-427C-A7E7-39308B17ADB9Q38367657-D0618DAA-7A71-4AE4-8EBA-DE2161F9136A
P2860
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@en
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@nl
type
label
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@en
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@nl
prefLabel
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@en
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@nl
P2093
P2860
P50
P1476
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
@en
P2093
Abdul Qader Sukkurwala
Eric Sulpice
Frederic Schlemmer
Nazanine Modjtahedi
Xavier Gidrol
P2860
P304
P356
10.1126/SCITRANSLMED.3003807
P407
P50
P577
2012-07-01T00:00:00Z